ARMISTICE CAPITAL, LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1601086 NEW YORK, NY

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$57,564,744

-$5,999,544 QoQ

Shares Held

3,175,110

-2.3% QoQ

Ownership

2.22%

of shares outstanding

% of Portfolio

1.91%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ARMISTICE CAPITAL, LLC holds $1,383,311,336 across 53 Biotechnology names. DYN ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	4,897,417	$145,502,259
2	PTCT	Ptc Therapeutics, Inc.	2,074,449	$141,332,210
3	MDGL	Madrigal Pharmaceuticals, Inc.	264,583	$138,501,263
4	AGIO	Agios Pharmaceuticals, Inc.	2,716,000	$91,882,280
5	IMVT	Immunovant, Inc.	3,564,916	$88,552,513
6	INCY	Incyte Corp	656,817	$61,819,616
7	DYN	Dyne Therapeutics, Inc. This page	3,175,110	$57,564,744
8	CYTK	Cytokinetics Inc	764,538	$50,390,699

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$57,564,744	3,175,110	-2.3%	Shares	Sole	2026-05-15
2025-12-31	$63,564,288	3,249,708	+6.1%	Shares	Sole	2026-02-17
2025-09-30	$38,759,600	3,064,000	+19.7%	Shares	Sole	2025-11-17
2025-06-30	$24,371,200	2,560,000	-7.5%	Shares	Sole	2025-08-14
2025-03-31	$28,953,280	2,768,000	+187.0%	Shares	Sole	2025-05-15
2024-12-31	$22,724,044	964,518	-16.5%	Shares	Sole	2025-02-14
2024-09-30	$41,494,927	1,155,204	+19.0%	Shares	Sole	2024-11-14
2024-06-30	$34,262,743	970,891	-2.9%	Shares	Sole	2024-08-14
2024-03-31	$28,390,000	1,000,000	+21.4%	Shares	Sole	2024-05-15
2023-12-31	$10,959,200	824,000	-31.3%	Shares	Sole	2024-02-13
2023-09-30	$10,752,000	1,200,000	+31.6%	Shares	Sole	2023-11-14
2023-06-30	$10,260,000	912,000	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.